Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Halozyme, Inc. patents

Patents where

Current Assignee

Name

‌

Halozyme, Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10016491 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases	Patent 10016491 was granted and assigned to Halozyme, Inc. on July, 2018 by the United States Patent and Trademark Office.	‌ Halozyme, Inc.	‌ Halozyme, Inc.	United States Patent and Trademark Office	10016491	July 10, 2018
‌ US Patent 8431380 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof	Patent 8431380 was granted and assigned to Halozyme, Inc. on April, 2013 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	8431380	April 30, 2013
‌ US Patent 7767429 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof	Patent 7767429 was granted and assigned to Halozyme, Inc. on August, 2010 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	7767429	August 3, 2010
‌ US Patent 10588983 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases	Patent 10588983 was granted and assigned to Halozyme, Inc. on March, 2020 by the United States Patent and Trademark Office.	‌ Halozyme, Inc.	‌ Halozyme, Inc.	United States Patent and Trademark Office	10588983	March 17, 2020
‌ US Patent 7829081 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases	Patent 7829081 was granted and assigned to Halozyme, Inc. on November, 2010 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	7829081	November 9, 2010
‌ US Patent 8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof	Patent 8202517 was granted and assigned to Halozyme, Inc. on June, 2012 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	8202517	June 19, 2012
‌ US Patent 7871607 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases	Patent 7871607 was granted and assigned to Halozyme, Inc. on January, 2011 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	7871607	January 18, 2011
‌ US Patent 8257699 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases	Patent 8257699 was granted and assigned to Halozyme, Inc. on September, 2012 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	8257699	September 4, 2012
‌ US Patent 7846431 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases	Patent 7846431 was granted and assigned to Halozyme, Inc. on December, 2010 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	7846431	December 7, 2010
‌ US Patent 8105586 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases	Patent 8105586 was granted and assigned to Halozyme, Inc. on January, 2012 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	8105586	January 31, 2012
‌ US Patent 10328130 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions	Patent 10328130 was granted and assigned to Halozyme, Inc. on June, 2019 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	10328130	June 25, 2019
‌ US Patent 7544499 Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof	Patent 7544499 was granted and assigned to Halozyme, Inc. on June, 2009 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	7544499	June 9, 2009
‌ US Patent 8450470 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof	Patent 8450470 was granted and assigned to Halozyme, Inc. on May, 2013 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	8450470	May 28, 2013
‌ US Patent 8431124 Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP)	Patent 8431124 was granted and assigned to Halozyme, Inc. on April, 2013 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	8431124	April 30, 2013
‌ US Patent 9683985 Methods for assessing and identifying or evolving conditionally active therapeutic proteins	Patent 9683985 was granted and assigned to Halozyme, Inc. on June, 2017 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	9683985	June 20, 2017
‌ US Patent 9677061 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof	Patent 9677061 was granted and assigned to Halozyme, Inc. on June, 2017 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	9677061	June 13, 2017
‌ US Patent 8187855 Large-scale production of soluble hyaluronidase	Patent 8187855 was granted and assigned to Halozyme, Inc. on May, 2012 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	8187855	May 29, 2012
‌ US Patent 9913822 Combination therapy with an anti-hyaluronan agent and therapeutic agent	Patent 9913822 was granted and assigned to Halozyme, Inc. on March, 2018 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	9913822	March 13, 2018
‌ US Patent 7718428 Myeloid colony stimulating factor and uses thereof	Patent 7718428 was granted and assigned to Halozyme, Inc. on May, 2010 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	7718428	May 18, 2010
‌ US Patent 8343487 Large-scale production of soluble hyaluronidase	Patent 8343487 was granted and assigned to Halozyme, Inc. on January, 2013 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	8343487	January 1, 2013
‌ US Patent 9333244 Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia	Patent 9333244 was granted and assigned to Halozyme, Inc. on May, 2016 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	9333244	May 10, 2016
‌ US Patent 11041149 PH20 polypeptide variants, formulations and uses thereof	Patent 11041149 was granted and assigned to Halozyme, Inc. on June, 2021 by the United States Patent and Trademark Office.	‌ Halozyme, Inc.	‌ Halozyme, Inc.	United States Patent and Trademark Office	11041149	June 22, 2021
‌ US Patent 9284543 Neutral active soluble truncated PH20 polypeptides and uses thereof	Patent 9284543 was granted and assigned to Halozyme, Inc. on March, 2016 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	9284543	March 15, 2016
‌ US Patent 9447401 PH20 polypeptide variants, formulations and uses thereof	Patent 9447401 was granted and assigned to Halozyme, Inc. on September, 2016 by the United States Patent and Trademark Office.		‌ Halozyme, Inc.	United States Patent and Trademark Office	9447401	September 20, 2016
‌ US Patent 11066656 PH20 polypeptide variants, formulations and uses thereof	Patent 11066656 was granted and assigned to Halozyme, Inc. on July, 2021 by the United States Patent and Trademark Office.	‌ Halozyme, Inc.	‌ Halozyme, Inc.	United States Patent and Trademark Office	11066656	July 20, 2021

Results per page:

63 results

0 selected

63 results

0 selected